Abstract:The serine-threonine kinase, tumor progression locus 2 (Tpl2, also known as Map3k8/Cot), is a potent inflammatory mediator that drives the production of TNFα, IL-1β, and IFNγ. We previously demonstrated that Tpl2 regulates TCR signaling and modulates T helper cell differentiation. However, very little is known about how Tpl2 modulates the development of regulatory T cells (Tregs). Tregs are a specialized subset of T cells that express FoxP3 and possess immunosuppressive properties to limit excess inflammation. Because of the documented role of Tpl2 in promoting inflammation, we hypothesized that Tpl2 antagonizes Treg development and immunosuppressive function. Herein, we demonstrate that Tpl2 constrains the development of inducible Tregs (iTregs). Tpl2 naïve CD4 T cells preferentially develop into FoxP3 iTregs in vitro as well as in vivo in a murine model of OVAinduced systemic tolerance. Treg biasing of Tpl2 T cells depended upon the TCR signal strength and corresponded with reduced activation of the mammalian target of rapamycin (mTOR) pathway. Importantly, Tpl2 Tregs have basally increased expression of FoxP3 and immunosuppressive molecules, IL-10 and cytotoxic T lymphocyteassociated protein 4 (CTLA-4). Furthermore, they were more immunosuppressive in vivo in a T cell transfer model of colitis, as evidenced by reducing effector T cell accumulation, systemic production of inflammatory cytokines, and colonic inflammation. These results demonstrate that Tpl2 promotes inflammation in part by constraining FoxP3 expression and Treg immunosuppressive functions. Overall these findings suggest that Tpl2 inhibition could be used to preferentially drive Treg induction and thereby limit inflammation in a variety of autoimmune diseases. INTRODUCTION Pathogenesis of a number of autoimmune diseases is attributed to self-reactive T cells that recognize self-antigens and trigger organ-specific damage (1). Regulatory T cells are a specialized lineage of T cells with immunosuppressive properties. The forkhead box P3 (FoxP3) transcription factor is important in specifying this lineage (2,3), and humans with mutations in the Foxp3 gene develop severe multi-organ autoimmune disease including autoimmune enteropathy, dermatitis, thyroiditis, and type I diabetes (4). This syndrome is highly homologous to that observed in scurfy mice that also harbor mutations within the Foxp3 gene (5). Tregs arise naturally in the thymus (natural Tregs, nTregs or thymus-derived Tregs, tTregs) or can be induced from naïve conventional T cells in the periphery (inducible Tregs; iTregs) (6-9). Both types of FoxP3 Tregs exhibit critical immunoregulatory functions to maintain central and peripheral http://www.jbc.org/cgi/doi/10.1074/jbc.M116.718783 The latest version is at JBC Papers in Press. Published on June 3, 2016 as Manuscript M116.718783 Copyright 2016 by The American Society for Biochemistry and Molecular Biology, Inc. by gest on N ovem er 8, 2017 hp://w w w .jb.org/ D ow nladed from

Itk-mediated integration of T cell receptor and cytokine signaling regulates the balance between Th17 and regulatory T cells

Interleukin-2-inducible T-cell kinase (Itk) signaling regulates potent noncanonical regulatory T cells

Itk Signaling Via the Ras/Irf4 Pathway Regulates the Development and Function of Type 1 Regulatory T Cells

Hierarchy of signaling thresholds downstream of the T cell receptor and the Tec kinase ITK

The Role of Tyrosine Kinase Itk in T helper 17 and T regulatory cells in Hypersensitivity Pneumonitis

Inactivation of the Enzyme GSK3α by the Kinase IKKi Promotes AKT-mTOR Signaling Pathway that Mediates Interleukin-1-Induced Th17 Cell Maintenance

Balancing immune activation with Itk

T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR

Pim-2 Kinase Influences Regulatory T Cell Function and Stability by Mediating Foxp3 Protein N-terminal Phosphorylation

TCR Signaling Induces STAT3 Phosphorylation to Promote TH17 Cell Differentiation.

Differential regulation of Foxp3 and IL-17 expression in CD4 T helper cells by IRAK-1

Integration of IL-2 and IL-4 signals coordinates divergent regulatory T cell responses and drives therapeutic efficacy

TSC 1 Regulates the Balance Between Effector and Regulatory T Cells

Tumor progression locus 2 ( Tpl 2 ) activates the mTOR pathway , inhibits FoxP 3 expression and limits Treg immunosuppressive functions

Initial TCR Signal Strength Imprints GATA3 and Tbet Expression Driving T-helper Cell Fate Decisions

Differential regulation of PTEN and Akt by TCR signal strength controls CD4+ T cell fate decisions (LYM8P.627)

Signaling pathway(s) of TNFR2 required for the immunoregulatory effect of CD4+Foxp3+ regulatory T cells

Signal transduction pathways and transcriptional regulation in the control of Th17 differentiation

Disruption of Tsc1/2 Signaling Complex Reveals A Checkpoint Governing Thymic Cd4(+)Cd25(+)Foxp3(+), Regulatory T-Cell Development in Mice

Nemo-like Kinase Drives Foxp3 Stability and is Critical for Maintenance of Immune Tolerance by Regulatory T Cells.

Interleukin-2 Signaling Via STAT5 Constrains T Helper 17 Cell Generation.